Overview

Detailed Summary

Procter & Gamble Health Limited focuses on manufacturing and marketing pharmaceuticals and chemicals, specializing in consumer health products with a strong emphasis on vitamins and supplements.
The company has demonstrated a consistent revenue growth trajectory, achieving a sales increase of 8% and profit growth of 27% over the last fiscal year, despite a challenging macroeconomic environment.
Leveraging an Integrated Growth Strategy, the company excels in delivering product superiority across multiple vectors, enhancing its market position and consumer loyalty.
There's a strong emphasis on broadening market reach, evidenced by increased product availability in e-commerce and rural areas, reinforcing its distribution model transformation.
Procter & Gamble Health takes an active role in community health initiatives through its SEHAT CSR program, aiming to improve healthcare accessibility and preventive education among underserved communities.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 10,449 Cr
Volatility: Low Risk
P/E Ratio: 32.0
Industry P/E: 34.1
PEG Ratio: 2.7
P/B Ratio: 19.6
52W High: 6,701.40
52W Low: 4,699.70

Sales CAGR

1Y: -18.86%
3Y: —
5Y: —
10Y: —

Profit CAGR

1Y: 16.63%
3Y: —
5Y: —
10Y: —

ROE

TTM: 62.32%
3Y: 43.66%
5Y: 43.66%
10Y: 43.66%

ROCE

TTM: 84.14%
3Y: 53.90%
5Y: 53.90%
10Y: 53.90%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
MARKSANS		250.50	11,313 Cr	27.07	3.74	0.36	13.82	17.37	10.88
VIYASH		249.35	10,893 Cr	68.18	3.74	0.00	7.07	13.01	4.44
SANOFICONR		4578.00	10,564 Cr	40.96	27.51	1.63	62.53	75.60	47.15
SHILPAMED		542.30	10,540 Cr	43.32	4.07	0.11	9.39	10.73	6.57
CORONA		1680.00	10,279 Cr	55.53	13.76	0.59	24.79	27.13	15.36
PGHL		6190.00	10,271 Cr	31.42	19.58	6.71	62.32	84.14	38.86
AKUMS		608.65	9,580 Cr	37.54	2.89	0.48	7.70	10.95	4.71
Median: 7 Co.	—	608.65	10,540 Cr	40.96	4.07	0.48	13.82	17.37	10.88

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	310	252	284	313	310	311	339	325	374	370
Expenses	208	185	236	199	186	230	248	205	263	235
Operating Profit	102	67	48	114	123	81	90	120	110	136
OPM %	32.79	26.71	17.00	36.39	39.85	26.02	26.67	37.02	29.55	36.60
Other Income	5.18	2.27	-18	3.28	3.96	3.11	4.03	4.95	4.36	4.00
Interest	0.19	0.15	0.20	0.15	0.15	0.13	0.12	0.12	0.10	0.21
Depreciation	6.92	6.84	7.16	5.77	5.55	5.37	5.44	6.08	5.90	6.17
Profit Before Tax	100	63	23	111	122	79	89	119	109	133
Tax %	27.73	25.77	26.50	26.10	25.30	22.09	25.48	25.61	28.70	28.98
Net Profit	72	47	17	82	91	61	66	89	78	95
EPS in Rs	43.40	28.00	9.50	49.60	54.76	36.86	39.87	53.34	46.74	56.99

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Dec 2016	Dec 2017	Dec 2018	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	TTM
Sales	1,030	711	849	1,356	1,009	1,114	1,230	1,151	934	1,273
Expenses	877	621	701	1,040	763	847	905	845	616	864
Operating Profit	153	90	148	315	246	268	325	306	318	409
OPM %	14.84	12.69	17.45	23.26	24.39	24.02	26.40	26.58	34.08	32.11
Other Income	24	41	31	69	18	13	18	-4.56	10	14
Interest	0.00	0.00	0.00	0.00	0.80	0.42	0.77	0.72	0.43	0.55
Depreciation	25	19	21	29	30	27	28	27	17	22
Profit Before Tax	115	99	158	355	233	253	314	273	312	400
Tax %	31.29	38.29	35.60	28.40	24.21	24.02	26.97	26.47	24.78	24.93
Net Profit	79	61	102	254	177	193	229	201	234	301
EPS in Rs	—	—	—	—	—	—	—	—	150.72	196.94
Dividend Payout %	23.06	26.50	87.08	150.33	121.50	45.26	68.84	214.88	88.65	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025
Equity Capital	17	17	17	17	17	17	17	17	17	17
Reserves	575	647	717	1,524	890	687	600	734	522	520
Borrowings	0.00	0.00	0.00	0.00	0.00	7.61	2.83	12	9.56	7.62
Other Liabilities	192	215	258	219	269	275	269	338	247	250
Total Liabilities	784	879	991	1,759	1,176	986	888	1,101	794	794
Fixed Assets	132	111	115	100	98	101	109	142	127	112
CWIP	7.00	30	8.90	17	21	39	41	32	5.89	11
Investments	42	28	70	3.82	3.30	2.95	2.60	2.25	1.90	4.37
Other Assets	603	711	797	1,639	1,053	843	736	925	660	667
Total Assets	784	879	991	1,759	1,176	986	888	1,101	794	794

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025
Cash from Operating Activity	83	107	54	-130	235	247	170	—	—	169
Cash from Investing Activity	-68	-75	-48	1,270	165	-32	-26	0.00	0.00	9.59
Cash from Financing Activity	-12	-15	-22	-30	-883	-387	-289	—	—	-235
Net Cash Flow	3.71	17	-16	1,109	-483	-172	-145	0.00	0.00	-56

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%
FIIs	7.15%	7.38%	7.59%	6.24%	6.40%	6.61%	7.01%	6.87%	6.99%	7.24%	6.97%	6.20%
DIIs	12.30%	12.31%	12.67%	13.73%	14.56%	14.84%	14.71%	14.21%	14.16%	13.91%	13.84%	13.68%
Public	28.74%	28.49%	27.92%	28.21%	27.23%	26.74%	26.46%	27.11%	27.03%	27.04%	27.37%	28.31%
Total Shareholders	58,856	57,919	56,730	56,778	55,923	54,792	53,736	53,993	52,478	50,006	49,302	50,883

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY25

Investor Presentation

Q2 FY24

Investor Presentation

Q2 FY23

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q4 FY18

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Procter & Gamble Health Ltd

Procter & Gamble Health Ltd (PGHL) is currently trading at 6,295.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Procter & Gamble Health Limited focuses on manufacturing and marketing pharmaceuticals and chemicals, specializing in consumer health products with a strong emphasis on vitamins and supplements. The company has demonstrated a consistent revenue growth trajectory, achieving a sales increase of 8% and profit growth of 27% over the last fiscal year, despite a challenging macroeconomic environment. Leveraging an Integrated Growth Strategy, the company excels in delivering product superiority across multiple vectors, enhancing its market position and consumer loyalty. There's a strong emphasis on broadening market reach, evidenced by increased product availability in e-commerce and rural areas, reinforcing its distribution model transformation. Procter & Gamble Health takes an active role in community health initiatives through its SEHAT CSR program, aiming to improve healthcare accessibility and preventive education among underserved communities.

Over the past 52 weeks, Procter & Gamble Health Ltd has traded between a low of ₹4,699.70 and a high of ₹6,701.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Procter & Gamble Health Ltd has a market capitalization of approximately 10,271.20. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Procter & Gamble Health Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 31.42 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 10,271.20 Cr, Procter & Gamble Health Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Procter & Gamble Health Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Procter & Gamble Health Ltd is 31.42. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Based on financial forecasts and market trends, the share price for Procter & Gamble Hygiene and Health Care is projected to reach a maximum target of ₹24,000 by the end of 2030, assuming continued operational performance.

Procter Gamble Health Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Procter & Gamble Health Ltd

What is Procter & Gamble Health Ltd share price today?

What does Procter & Gamble Health Ltd do?

What is the 52-week high and low of Procter & Gamble Health Ltd?

What is the market capitalization of Procter & Gamble Health Ltd?

Should I consider investing in Procter & Gamble Health Ltd stock?

Is Procter & Gamble Health Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Procter & Gamble Health Ltd belong to and why does it matter?

What is the PE ratio of Procter & Gamble Health Ltd?

What is the projected share price target for P&G Hygiene and Health Care by 2030?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Procter & Gamble Health Ltd

What is Procter & Gamble Health Ltd share price today?

What does Procter & Gamble Health Ltd do?

What is the 52-week high and low of Procter & Gamble Health Ltd?

What is the market capitalization of Procter & Gamble Health Ltd?

Should I consider investing in Procter & Gamble Health Ltd stock?

Is Procter & Gamble Health Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Procter & Gamble Health Ltd belong to and why does it matter?

What is the PE ratio of Procter & Gamble Health Ltd?

What is the projected share price target for P&G Hygiene and Health Care by 2030?

Announcements

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist

Oscillators

Neutral

Overall

Bullish

Moving Averages

Bullish

Overall

Bullish